Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

PRESERFLO™ MicroShunt XI Observational PMCF Study With no Control Group

The purpose of this study is to collect safety and performance data on the PRESERFLO™ MicroShunt XI in patients diagnosed with primary open angle glaucoma who are inadequately controlled on maximum tolerated medical therapy with intraocular pressure ≥18 mmHg and ≤35 mmHg and/or where glaucoma progression warrants surgery.

Participants needed: 112
Trial details
Age: 18-85Biological sex: AllType: ObservationalSponsor: Santen SASUpdated: May 29, 2026Locations: 11
Eligibility criteria

Male or female, age 18 to 85 years, inclusive [+3]

Angle closure glaucoma [+16]

Status: Recruiting

LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose) in the Treatment of Acquired Blepharoptosis.

A Randomised, Double-Masked, Placebo-Controlled Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops) used twice daily (BID) in the Treatment of Acquired Blepharoptosis

Participants needed: 234
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Santen SASUpdated: May 4, 2026Locations: 36
Eligibility criteria

Able to understand and sign an informed consent form prior to participation in a... [+8]

Congenital ptosis. [+19]